Clinical trial
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
NCT04343521 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 3, 2020
- Completion date
- April 28, 2024
- Enrollment
- 4,461 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aedes-borne diseases, chikungunya, dengue, zika